Apogee Therapeutics Cash Flow Statement (2022-2026) | APGE

Cash Flow Statement Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -1.82M-10.51M-14.10M-12.53M-18.89M-20.84M43.63M-32.09M-33.82M-49.02M-67.22M-55.34M-66.10M-65.02M-69.39M-74.11M
Depreciation and Depletion (Quarter) 0.03M0.04M0.05M0.10M0.20M0.40M0.40M0.41M0.40M
Share-based Compensation (Quarter) 1.27M1.11M1.50M2.21M4.19M5.70M5.84M7.61M11.13M11.34M11.88M11.93M17.16M
Gains from Sales and Divestitures (Quarter) 0.12M0.44M0.23M0.51M0.71M0.04M0.19M0.04M0.58M0.78M0.19M
Gains from Investment Securities (Quarter) 2.76M4.62M0.64M2.51M2.62M0.02M0.03M1.19M1.00M0.08M0.81M-0.15M
Non-cash Items (Quarter) 12.70M1.32M0.02M0.10M0.23M0.50M61.51M0.04M1.32M1.67M216.17M268.16M
Cash from Operations (Quarter) -9.19M-10.56M-14.57M-19.88M-29.75M-31.64M-29.30M-42.52M-67.71M-48.48M-62.03M-54.29M-62.65M-55.57M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 0.03M0.04M0.05M0.10M0.20M0.40M0.40M0.41M0.40M
Change in Working Capital
Change in Account Payables (Quarter) -1.08M0.38M0.48M9.86M-9.76M1.04M2.16M1.23M-3.31M-1.15M1.37M3.23M-5.30M0.84M0.02M
Change in Accured Expenses (Quarter) 4.35M1.90M0.26M-4.74M10.89M1.25M-1.75M1.84M10.12M-3.92M2.64M-5.04M7.74M-6.41M4.67M
Other Working Capital Changes (Quarter) 0.04M1.92M1.44M-3.67M-0.26M2.94M2.81M0.60M-1.01M-0.97M5.73M-1.64M2.49M
Investing Activities
Capital Expenditures (Quarter) 0.35M0.05M0.75M-0.00M0.23M4.86M0.06M
Change in Acquisitions & Divestments (Quarter) 74.50M78.31M90.38M106.95M115.50M126.27M125.58M100.52M147.90M
Cash from Investing Activities (Quarter) -39.69M-51.74M-148.71M-146.38M46.37M12.98M78.12M17.95M-288.63M-35.35M
Financing Activities
Other financing activities (Quarter) 1.27M1.11M177.47M-173.75M4.19M5.70M5.84M7.61M11.13M11.34M11.88M11.93M17.16M
Cash from Financing Activities (Quarter) 4.85M158.50M317.30M-0.21M450.52M-0.15M0.38M44.36M0.62M1.18M19.74M374.95M411.17M
Additional items
Change in Cash (Quarter) -2.39M149.31M-10.56M-16.26M63.20M-69.66M367.14M-178.16M-188.52M23.01M-34.87M17.28M-16.57M23.64M320.25M
Free Cash Flow (Quarter) -9.19M-10.56M-14.57M-19.88M-29.75M-31.99M-29.35M-43.27M-67.71M-48.71M-66.89M-54.29M-62.71M-55.57M
Net Cash Flow (Quarter) 4.85M149.31M-10.56M-14.57M297.42M-69.66M367.14M-178.16M-188.52M23.01M-34.87M17.28M-16.61M23.67M320.25M